Medical Imaging

Physicians utilize medical imaging to see inside the body to diagnose and treat patients. This includes computed tomography (CT), magnetic resonance imaging (MRI), X-ray, ultrasound, fluoroscopy, angiography,  and the nuclear imaging modalities of PET and SPECT. 

Thumbnail

AI tool helps identify 'invisible' head injuries on MRIs of college athletes

The tool uses a machine learning technique to identify changes on brain MRIs that would otherwise be overlooked by radiologists due to the subtlety of alterations. 

chest pain lung pulmonary embolism

How CT creates barrier to treating pulmonary embolism patients in cheaper outpatient settings

Rather than being discharged, low-risk PE patients often receive unnecessary additional services and overnight stays, experts wrote in JAMA.

Thumbnail

FDA clears GE HealthCare’s AI solution for enhancing PET/CT image quality

Precision DL was engineered using a deep neural network, trained with thousands of images, the Chicago-based company said May 30. 

Thumbnail

Ultrasound AI could help standardize trauma care

Trauma patients who present with poor blood flow and suspected abdominal hemorrhage are well served by emergency physicians using AI-augmented FAST imaging.

Thumbnail

Important factors that influence radiology practices’ patient experience scores

Mayo Clinic researchers administered their survey to 3,636 patients who underwent outpatient MRI exams, sharing the results in JACR

mergers and acquisitions M&A puzzle

Block Imaging spinning off mobile business after announcing its acquisition by Siemens, CommonSpirit

Cube Mobile Imaging, as it’s now called, will not be involved in the transaction, instead continuing to operate as a standalone, family-owned business

money maze payment reimbursement

Imaging advocacy group slams ‘extremely restrictive’ Medicare coverage determination

A Medicare Administrative Contractor is wrongly rejecting coverage of PET imaging in cases of infection/inflammation, SNMMI reported recently. 

prostate cancer PSA

FDA approves new PSMA-targeted PET imaging agent for prostate cancer

Blue Earth Diagnostics said this is the first and only PSMA-targeted imaging agent developed with its proprietary radiohybrid technology.